Navigation

NICE guidance having significant impact according to study

NICE welcomes the NHS Information Centre report on the uptake of NICE-appraised medicines in the NHS. Andrew Dillon, Chief Executive of NICE, said: “This new report shows that NICE guidance is having a significant impact on the treatment and care that patients receive from the NHS. It is also a recognition that NICE and its guidance is seen to represent value for money for the NHS. As the NHS moves into a period of financial stringency it is being asked to focus on not just ensuring quality care but also on increasing productivity and innovation. It is therefore important that what NICE does, across the range of guidance that it produces, continues to reflect those priorities. It is equally important for local PCTs to ensure they are implementing NICE guidance appropriately and to help them do that NICE provides a range of tailored implementation support tools, including costing templates and slide sets, as well as a team of regional Implementation Consultants.”

Issued: 9 September 2009

This page was last updated: 15 January 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.